Morepen Laboratories’ mega expansion plan awaits green nodIllustrative image – not actual.
Morepen Laboratories’ is awaiting environmental clearance (EC) from the State Level Approval Committee for expansion of its APIs manufacturing capacity in Himachal Pradesh. 
 
The Board of Directors of the company had approved the mega expansion plan involving an outlay of Rs 178 crore on 31 August 2020. The company proposes to fund the expansion primarily through internal accruals. 
 
The project has already been cleared by the Himachal Pradesh government under Single Window Clearance Scheme. 
 
It would add 2,000 tpa of APIs manufacturing capacity in addition to 3,000 tpa capacity already installed. The project will generate additional employment for about 700 people. 
 
The additional capacities will facilitate production of over 40 new and existing bulk drugs covering various therapeutic categories including anti-diabetic, anti-hypertensives, anti-allergic, anti-asthmatic, cholesterol reducers, anti-viral, anti-coagulants, anti-psychotic and anti-depressants. 
 
The expanded capacity is likely to commence commercial production over the next three years.
← All latest storiesBack to top →